MCM
ZBH icon

MAI Capital Management’s Zimmer Biomet ZBH Stock Holding History

MAI Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,339
Closed -$131K – 576
2020
Q1 		$131K Buy
+1,339
New +$176K 0.01% 509

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MAI Capital Management's ZBH Position: Q2 2026 in Review

MAI Capital Management reduced its Zimmer Biomet (ZBH) stake by 4.9% in Q2 2026, selling an estimated $11K and leaving 2,425 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

MAI Capital Management first reported a position in ZBH in Q1 2020 and has held it in 26 quarters since. The position peaked at $605K in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • MAI Capital Management held 2,425 shares of Zimmer Biomet worth $209K as of Q2 2026.
  • MAI Capital Management sold 125 Zimmer Biomet shares in Q2 2026, an estimated $11K.
  • Zimmer Biomet made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1791 holding.
  • MAI Capital Management first reported a position in Zimmer Biomet in Q1 2020 and has held it in 26 quarters since.
  • MAI Capital Management's Zimmer Biomet position peaked at $605K in Q2 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.